Zhijian Huang Selected Research

Zhijian Huang Research Topics

Disease

19	Neoplasms (Cancer) 02/2024 - 06/2018
12	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022 - 01/2016
6	Colorectal Neoplasms (Colorectal Cancer) 05/2024 - 01/2021
4	Microsatellite Instability 02/2024 - 01/2022
4	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2020
4	Infections 11/2021 - 01/2011
4	Inflammation (Inflammations) 01/2019 - 10/2017
3	Triple Negative Breast Neoplasms 03/2024 - 01/2024
3	COVID-19 05/2023 - 01/2022
3	Brain Edema (Cerebral Edema) 01/2022 - 03/2016
3	Brain Injuries (Brain Injury) 01/2021 - 01/2016
3	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2019 - 12/2015
2	Thrombocytopenia (Thrombopenia) 01/2024 - 05/2021
2	Carcinogenesis 01/2023 - 03/2021
2	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2021
2	Dysbiosis 01/2021 - 10/2020
2	Parkinson Disease (Parkinson's Disease) 10/2019 - 01/2018
2	Neuroinflammatory Diseases 01/2019 - 11/2017
2	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 01/2018
2	Ischemic Stroke 01/2018 - 01/2016
1	Demyelinating Diseases (Demyelinating Disease) 04/2024
1	Hand-Foot Syndrome 01/2024
1	Fatigue 01/2024
1	Proteinuria 01/2024
1	Hypertension (High Blood Pressure) 01/2024
1	Neutropenia 01/2024
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2024
1	Nausea 01/2024
1	Alopecia (Baldness) 01/2024
1	Vomiting 01/2024
1	Severe Acute Respiratory Syndrome 05/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023
1	Macular Edema 10/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Parasitic Diseases (Parasitic Disease) 11/2021
1	Tufted angioma 05/2021
1	Kaposiform Hemangioendothelioma 05/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2021
1	Carcinoma (Carcinomatosis) 03/2021
1	Hemorrhage 01/2021
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021
1	Necrosis 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Kidney Neoplasms (Kidney Cancer) 01/2020
1	Liver Neoplasms (Liver Cancer) 01/2020

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2020
13	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2011
6	Messenger RNA (mRNA)IBA 05/2023 - 01/2016
5	RNA (Ribonucleic Acid)IBA 05/2023 - 01/2021
4	Bexarotene (LGD1069)FDA Link 12/2020 - 01/2017
4	ApolipoproteinsIBA 01/2019 - 03/2016
3	Nucleic AcidsIBA 05/2023 - 11/2021
3	Long Noncoding RNAIBA 01/2022 - 01/2016
3	Therapeutic UsesIBA 05/2021 - 10/2017
3	pigment epithelium-derived factorIBA 01/2020 - 06/2018
2	Tumor Biomarkers (Tumor Markers)IBA 04/2024 - 01/2022
2	apatinibIBA 03/2024 - 01/2024
2	N-methyladenosineIBA 01/2023 - 01/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2022 - 06/2018
2	Angiogenesis InhibitorsIBA 01/2020 - 10/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 05/2019
2	LipopolysaccharidesIBA 01/2018 - 11/2017
2	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 01/2016
2	Apolipoproteins E (ApoE)IBA 01/2017 - 12/2015
2	Subunit VaccinesIBA 05/2015 - 12/2014
1	Membrane Proteins (Integral Membrane Proteins)IBA 05/2024
1	SterolsIBA 04/2024
1	Hormones (Hormone)IBA 02/2024
1	Phenobarbital (Luminal)FDA Link 02/2024
1	Alanine Transaminase (SGPT)IBA 01/2024
1	eribulin FDA Link 01/2024
1	Toll-Like Receptor 7IBA 05/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	MethyltransferasesIBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	5-Methylcytosine (5 Methylcytosine)IBA 01/2022
1	Tight Junction ProteinsIBA 01/2022
1	Temozolomide (Temodar)FDA LinkGeneric 01/2022
1	Interferon Type IIBA 01/2022
1	CateninsIBA 12/2021
1	Vincristine (Oncovin)FDA LinkGeneric 05/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2021
1	Fibrinogen (Factor I)FDA Link 05/2021
1	Carrier Proteins (Binding Protein)IBA 03/2021
1	ElementsIBA 03/2021
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2021
1	Annexin A1IBA 01/2021
1	InterferonsIBA 01/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2020
1	Sorafenib (BAY 43-9006)FDA Link 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020

Therapy/Procedure

8	Therapeutics 01/2023 - 03/2016
4	Drug Therapy (Chemotherapy) 01/2024 - 01/2016
3	Vitrectomy 10/2022 - 03/2017
2	Immunotherapy 02/2024 - 01/2022
2	Fecal Microbiota Transplantation 01/2021 - 10/2020
1	Aftercare (After-Treatment) 01/2022